Loading…
Analysis of the humoral and cellular response after the third COVID‐19 vaccination in patients with autoimmune hepatitis
Background & aims To explore the humoral and T‐cell response to the third COVID‐19 vaccination in autoimmune hepatitis (AIH). Methods Anti‐SARS‐CoV‐2 antibody titers were prospectively determined in 81 AIH patients and 53 healthy age‐ and sex‐matched controls >7 days (median 35) after the fir...
Saved in:
Published in: | Liver international 2023-02, Vol.43 (2), p.393-400 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background & aims
To explore the humoral and T‐cell response to the third COVID‐19 vaccination in autoimmune hepatitis (AIH).
Methods
Anti‐SARS‐CoV‐2 antibody titers were prospectively determined in 81 AIH patients and 53 healthy age‐ and sex‐matched controls >7 days (median 35) after the first COVID‐19 booster vaccination. The spike‐specific T‐cell response was assessed using an activation‐induced marker assay (AIM) in a subset of patients.
Results
Median antibody levels were significantly lower in AIH compared to controls (10 908 vs. 25 000 AU/ml, p |
---|---|
ISSN: | 1478-3223 1478-3231 |
DOI: | 10.1111/liv.15368 |